William Resides
Amministratore Delegato presso BIOREGENX, INC.
Patrimonio netto: 661 572 $ in data 31/05/2024
Posizioni attive di William Resides
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| BIOREGENX, INC. | Direttore/Membro del Consiglio | 08/03/2024 | - |
| Amministratore Delegato | 08/03/2024 | - |
Storia della carriera di William Resides
Precedenti posizioni note di William Resides
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
NuLife Sciences, Inc.
 NuLife Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services NuLife Sciences, Inc. a biomedical company, which engages in advancing human organ transplant and tissue repair technology, and medical research. The company was founded by Derek Cahill on October 15, 2013 and is headquartered in Newport Beach, CA. | Amministratore Delegato | 02/01/2019 | - |
| Fondatore | 02/01/2019 | - | |
BioRegenx, Inc.
 BioRegenx, Inc. Pharmaceuticals: OtherHealth Technology Part of Findit, Inc., BioRegenx, Inc. is a holding company that consists of Microvascular Health Solutions, LLC, My Body RX, LLC, and NuLife Sciences, Inc. The company is based in Chattanooga, TN. The company and its subsidiaries offer 360-degree solutions, which include leading-edge testing technologies and nutraceutical solutions. The patented Endocalyx Pro™ and additional synergistic dietary supplements sold under the My Body RX brand are part of the nutraceuticals offered. The customer base of BioRegenx subsidiaries includes medical professionals, brand partners, and consumers from throughout North America. The CEO of the company is William Resides. BioRegenx was acquired by Findit, Inc. on March 31, 2023. | Direttore/Membro del Consiglio | - | - |
| Amministratore Delegato | - | - | |
| Fondatore | - | - |
Statistiche
Distribuzione geografica
| Stati Uniti | 3 |
| 2 |
Posizioni
| Chief Executive Officer | 3 |
| Director/Board Member | 2 |
| Founder | 2 |
Settori
| Commercial Services | 2 |
| Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 3 |
|---|---|
NuLife Sciences, Inc.
NuLife Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services NuLife Sciences, Inc. a biomedical company, which engages in advancing human organ transplant and tissue repair technology, and medical research. The company was founded by Derek Cahill on October 15, 2013 and is headquartered in Newport Beach, CA. | Commercial Services |
| Findit, Inc. | |
BioRegenx, Inc.
BioRegenx, Inc. Pharmaceuticals: OtherHealth Technology Part of Findit, Inc., BioRegenx, Inc. is a holding company that consists of Microvascular Health Solutions, LLC, My Body RX, LLC, and NuLife Sciences, Inc. The company is based in Chattanooga, TN. The company and its subsidiaries offer 360-degree solutions, which include leading-edge testing technologies and nutraceutical solutions. The patented Endocalyx Pro™ and additional synergistic dietary supplements sold under the My Body RX brand are part of the nutraceuticals offered. The customer base of BioRegenx subsidiaries includes medical professionals, brand partners, and consumers from throughout North America. The CEO of the company is William Resides. BioRegenx was acquired by Findit, Inc. on March 31, 2023. | Health Technology |
- Borsa valori
- Insiders
- William Resides
- Esperienza
